Boston Scientific

This Veterans Day, we honor those who served — including Lauren and Jared, whose experiences as U.S. Army officers continue to shape how they lead at Boston Scientific today. From managing missions in the Middle East to guiding product launches that help millions of patients, they’ve found a renewed sense of service and purpose on our team. #AdvancingTogether Read more: https://lnkd.in/g4cgTj_9

Picture this. You’re on the verge of going into heart failure, but you don’t know it yet—because it won’t happen for another month. Luckily, your vital signs are being monitored by an algorithm that detects the early warning signals. It alerts your doctor, who takes immediate action to prevent potential catastrophe. Believe it or not, this is one way AI is already revolutionizing the practice of medicine. Learn how physicians are currently unlocking insights using AI, ushering in a new era of proactive cardiac care.

Leakage happens – and more often than you might think. Did you know: - 𝟭 𝗶𝗻 𝟮 U.S. women experience the involuntary leakage of urine, due in part to the stresses of pregnancy, childbirth and menopause - Men are also affected: About 𝟭 𝗶𝗻 𝟭𝟬 men in the U.S. suffer from urinary incontinence, with rates rising for those over age 60 In honor of Bladder Health Month, learn more about symptoms and treatments for two common conditions: stress urinary incontinence and overactive bladder.

After receiving the WATCHMAN Left Atrial Appendage Closure device to reduce stroke risk in 2023, Boston Scientific R&D engineer Laine's dad was able to celebrate her wedding this summer – and look forward to more family celebrations to come. “I don’t even know what life would look like without WATCHMAN,” says Laine. #WorldStrokeDay

"We delivered another exceptional quarter of strong performance across businesses and regions thanks to the winning spirit of our global team," says Mike Mahoney, chairman and chief executive officer, Boston Scientific. “As we shared at our recent Investor Day meeting, we are well-positioned for differentiated growth that is fueled by our category leadership strategy, relentless focus on innovation and commitment to scaling capabilities.” Here are a few key takeaways from our earnings announcement: https://lnkd.in/gatc8xHZ

Boston Scientific announces results for Q3 2025: https://lnkd.in/gQtNYQuc

Today we hosted a ribbon cutting ceremony to celebrate the opening of our Arbor Lakes facility in Maple Grove, Minnesota. Alongside state and local officials, our leaders reaffirmed our commitment to investing in Minnesota — where 10,000 Boston Scientific employees research, design and manufacture life-changing medical technologies. This new facility will support the continued growth of our Cardiovascular businesses and enable us to advance science for more patients around the world. #AdvancingTogether

Today, we announced a definitive agreement to acquire Nalu Medical, Inc., a medical technology company focused on developing and commercializing innovative and minimally-invasive solutions for patients with chronic pain. http://spklr.io/6043BKWMv

In 1 out of 10 cases, after a clogged artery is reopened via angioplasty (also called PCI), it clogs yet again, a condition called in-stent restenosis (ISR). Read in The Wall Street Journal about how the AGENT™ Drug Coated Balloon — now available in the U.S. — addresses a critical unmet need for ISR treatment, using tech that represents a “quantum leap” forward: http://spklr.io/6048BKJBk Custom Content from WSJ

This Manufacturing Month, we're celebrating the people behind our global supply chain who make it possible for our products to help millions of patients worldwide. Thank you for your dedication to advancing science for life. #AdvancingTogether